| Literature DB >> 27342419 |
Paula Rios1,2, Helen D Bailey1,2, Laurent Orsi1,2, Brigitte Lacour1,2,3, Dominique Valteau-Couanet4, Dominique Levy5, Nadège Corradini6, Guy Leverger7, Anne-Sophie Defachelles8, Marion Gambart9, Nicolas Sirvent10, Estelle Thebaud11, Stéphane Ducassou12, Jacqueline Clavel1,2.
Abstract
Neuroblastoma (NB), an embryonic tumour arising from neural crest cells, is the most common malignancy among infants. The aetiology of NB is largely unknown. We conducted a pooled analysis to explore whether there is an association between NB and preconception and perinatal factors using data from two French national population-based case-control studies. The mothers of 357 NB cases and 1783 controls younger than 6 years, frequency-matched by age and gender, responded to a telephone interview that focused on demographic, socioeconomic and perinatal characteristics, childhood environment, life-style and maternal reproductive history. Unconditional logistic regression was used to estimate pooled odds ratios and 95% confidence intervals. After controlling for matching variables, study of origin and potential confounders, being born either small (OR 1.4 95% CI 1.0-2.0) or large (OR 1.5 95% CI 1.1-2.2) for gestational age and, among children younger than 18 months, having congenital malformations (OR 3.6 95% CI 1.3-8.9), were significantly associated with NB. Inverse associations were observed with breastfeeding (OR 0.7 95% CI 0.5-1.0) and maternal use of any supplements containing folic acid, vitamins or minerals (OR 0.5 95% CI 0.3-0.9) during the preconception period. Our findings reinforce the hypothesis that fetal growth anomalies and congenital malformations may be associated with an increased risk of NB. Further investigations are needed in order to clarify the role of folic acid supplementation and breastfeeding, given their potential importance in NB prevention.Entities:
Keywords: childhood cancer; congenital malformations; fetal growth; neuroblastoma; risk factors
Mesh:
Year: 2016 PMID: 27342419 DOI: 10.1002/ijc.30239
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.396